✦ LIBER ✦

BASELINE RENAL FUNCTION AND CARDIOVASCULAR RISK IN PATIENTS TREATED WITH SAXAGLIPTIN: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL

✍ Scribed by Udell, Jacob A.; Scirica, Benjamin; Cavender, Matthew A.; Mosenzon, Ofri; Steg, Philippe; Davidson, Jaime; Hirshberg, Boaz; Im, Kyungah (Kelly); Raz, Itamar; Bhatt, Deepak

Book ID: 122240030
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 863 KB
Volume: 63
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(14)61526-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline characteristics of the patient

Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial

✍ Mosenzon, O.; Raz, I.; Scirica, B. M.; Hirshberg, B.; Stahre, C. I.; Steg, P. G. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

PROGNOSTIC IMPLICATIONS OF SIMULTANEOUS

PROGNOSTIC IMPLICATIONS OF SIMULTANEOUS BIOMARKER ASSESSMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL

✍ Scirica, Benjamin; Bhatt, Deepak; Braunwald, Eugene; Raz, Itamar; Steg, Philippe 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 874 KB

Correlates of Bleeding Events Among Mode

Correlates of Bleeding Events Among Moderate- to High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated With Eptifibatide: Observations From the PROTECT–TIMI-30 Trial

✍ Ajay J. Kirtane; Gregory Piazza; Sabina A. Murphy; Daniela Budiu; David A. Morro 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Distribution of Traditional and Novel Ri

Distribution of Traditional and Novel Risk Factors and Their Relation to Subsequent Cardiovascular Events in Patients With Acute Coronary Syndromes (from the PROVE IT-TIMI 22 Trial)

✍ Subroto Acharjee; Jie Qin; Sabina A. Murphy; Carolyn McCabe; Christopher P. Cann 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 678 KB

Assessment of adiponectin and the risk o

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22)

✍ Sean R. Wilson; Marc S. Sabatine; Stephen D. Wiviott; Kausik K. Ray; James A. De 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 278 KB

American College of Cardiology/American

American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death: Observations From the TRITON-TIMI 38 Trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38)

✍ Bonaca, M. P.; Wiviott, S. D.; Braunwald, E.; Murphy, S. A.; Ruff, C. T.; Antman 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 609 KB